Skip to main content

Advertisement

SpringerLink
Log in

Einsatz von Biologika bei der juvenilen idiopathischen Arthritis

Konsensus-Statement des 7. Wörlitzer Expertengespräches 2004 für die Arbeitsgemeinschaft Kinder- und Jugendrheumatologie

Biologics for treatment of juvenile idiopathic arthritis

Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie

  • Übersicht
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

Zusammenfassung

Die rasch wachsende Gruppe der Biologika stellt heute bereits einen unverzichtbaren Bestandteil bei der Behandlung von chronisch entzündlichen oder Autoimmunerkrankungen dar, nicht nur für bislang therapierefraktäre Krankheitsverläufe sondern auch, weil die Effektivität einer Therapie mit Biologika oftmals dem Ausmaß des konventionell erreichbaren Therapieerfolges überlegen ist, der Wirkungseintritt rascher erfolgt und das Therapierisiko geringer erscheint. Aus diesem Grunde soll mit der vorliegenden Stellungnahme eine aktualisierte Empfehlung zur Behandlung von Kindern und Jugendlichen erfolgen [6].

Summary

The group of biologics for the treatment of rheumatic diseases is continuously growing. They have become an important option not only for treatment of so far untreatable chronic inflammatory or rheumatic disease, but also for juvenile idiopathic arthritis. In addition, the velocity and the degree of improvement is better than with to conventional therapies. Furthermore, toxicity and risks seem to be lower with higher safety and compatibility. Although the data are scarce, they are widely used. Therefore, the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie is updating the current recommendation for the treatment of juvenile idiopathic arthritis using biologics [6].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Armbrust W, Kamphuis SS, Wolfs TW, Fiselier TJ, Nikkels PG, Kuis W, Wulffraat NAM (2004) Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis. Rheumatology 43(4): 527–529

    Article  CAS  PubMed  Google Scholar 

  2. Banares A, Abasolo L, Maccaron P, Hernandez C, Jover JA, Fernandez B, Pato E (2001) Treatment of refractory posterior uveitis with anti-TNF-alpha (infliximab). Arthritis Rheum 44:90S

    Google Scholar 

  3. Billiau AD, Cornillie F, Wouters C (2002) Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 children. J Rheumatol 29(5):1111–1114

    PubMed  Google Scholar 

  4. Henrickson M (2004) Efficacy of Anakinra in Refractory Systemic Arthritis. 2004 Annual Scientific meeting of the American College of Rheumatology, October 16-21, San Antonio, USA

  5. Horneff G, Biedermann T, Foeldvari I, Kuester RM, Moebius D, Michels H, Rogalski B, Schmeling H (2003) Combination therapy with methotrexate and etanercept compared to etanercept monotherapy. Clin Exp Rheumatol 21:540

    Google Scholar 

  6. Horneff G, Forster J, Seyberth H-W., Michels H, für die Arbeitsgemeinschaft Kinder- und Jugendrheumatologie (2001) Empfehlungen der Arbeitsgemeinschaft Kinder- und Jugendrheumatologie zur Therapie mit Etanercept (P75 TNF-Rezeptor-Immunglobulinfusionsprotein). Z Rheumatol 59:365–369

    Article  Google Scholar 

  7. Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, Hosbach T, Huppertz HI, Keitzer R, Kuester RM, Michels H, Moebius D, Rogalski B, Thon A (2004) The German Etanercept Registry for Treatment of Juvenile Idiopathic Arthritis (JIA). Ann Rheum Dis 63:1638–1644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ilowite NT, Porras O, Reiff A, Rudge SR, Punaro MG, Martin AL, Allen R, Harville TO, Kazazi F, Zhou L, Newmark R (2003) A twelve-week open label safety and efficacy study of anakinra (Kineret) in juvenile rheumatoid arthritis. Ann Rheum Dis 62:86S

    Article  Google Scholar 

  9. Irigoyen PI, Olson J, Hom C, Ilowite NT (2004) Treatment of Systemic Onset Juvenile Rheumatoid Arthritis with Anakinra. Annual Scientific meeting of the American College of Rheumatology, October 16–21, San Antonio, USA

  10. Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ (2004) Once weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis. Results of a multicenter, randomised, double-blind, placebo-controlled trial. Arthritis Rheum 50:353–363

    Article  CAS  PubMed  Google Scholar 

  11. Kimura Y, Imundo LF, Li SC (2001) High dose infliximab in the treatment of resistant systemic JRA. Arthritis Rheum 44:272S

    Google Scholar 

  12. Lahdenne P, Vahasalo P, Honkanen V (2003) Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 62:245–247

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lovell Dj, Giannini EH, Reiff A et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763–769

    Article  CAS  PubMed  Google Scholar 

  14. Lovell DJ, Ruperto N, Goodman S, Reiff A, Martini A, Giannini EH, Radin AR, Rao VS, Spencer-Green G (2004) Preliminary Data from the Study of Adalimumab in Children with Juvenile Idiopathic Arthritis (JIA). Annual Scientific meeting of the American College of Rheumatology, October 16–21, San Antonio, USA

  15. Manger B (2002) Überarbeitete Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie mit Tumornekrosefaktor-hemmenden Wirkstoffen bei entzündlich rheumatischen Erkrankungen (Stand Juli 2002). Z Rheumatol 61:694–697

    Article  CAS  PubMed  Google Scholar 

  16. Reiff A, Henrickson M (2001) Prolonged efficacy of etanercept in refractory juvenile ankylosing spondylitis. Arthritis Rheum 44:292S

    Article  Google Scholar 

  17. Reiff A, Porras O, Rudge S, Punaro M, Allen R, Ilowite N, Martin AL, Lovell D, Kazazi F, Sun G, Newmark R (2002) Preliminary Data from a Study of Kineret (anakinra) in Children with Juvenile Rheumatoid Arthritis. Annual Scientific meeting of the American College of Rheumatology, October 25–29, New Orleans, USA

  18. Reiff A, Takei S, Sadeghi S, Stout A, Shaham B, Bernstein B, Gallagher K, Stout T (2001) Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 44:1411–1415

    Article  CAS  PubMed  Google Scholar 

  19. Saadeh et al (2004) Successful treatment of Still’s disease with anakinra after failure to respond to multiple therapeutic modalities including methotrexate, infliximab, immunoglobulins, etanercept and adalimumab. Ann Rheum Dis 63:81S

    Google Scholar 

  20. Schmeling H, Mathony K, John V, Keyßer G, Burdach St., Horneff G (2001) Combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis – a pilot study. Ann Rheum Dis 60:410–412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Tutar E, Ekici F, Nacar N, Arici S, Atalay S (2004) Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford), 43(5):674–675

    Article  CAS  Google Scholar 

Download references

Interessenkonflikt:

Keine Angaben

Author information

Authors and Affiliations

  1. Universitätsklinik und Poliklinik für Kinder und Jugendmedizin, Halle

    G. Horneff

  2. Universitätsklinik und Poliklinik für Kinder und Jugendmedizin, Martin-Luther-Universität, 06097, Halle, Germany

    G. Horneff

Authors
  1. G. Horneff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horneff, G. Einsatz von Biologika bei der juvenilen idiopathischen Arthritis. Z Rheumatol 65, 152–158 (2006). https://doi.org/10.1007/s00393-005-0002-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-005-0002-7

Schlüsselwörter

Keywords

Search

Navigation